Calreticulin Mutations in Myeloproliferative Neoplasms

With the discovery of the JAK2V617F mutation in patients with Philadelphia chromosome-negative (Ph−) myeloproliferative neoplasms (MPNs) in 2005, major advances have been made in the diagnosis of MPNs, in understanding of their pathogenesis involving the JAK/STAT pathway, and finally in the developm...

Full description

Bibliographic Details
Main Author: Noa Lavi
Format: Article
Language:English
Published: Rambam Health Care Campus 2014-10-01
Series:Rambam Maimonides Medical Journal
Subjects:
Online Access:http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=432